It was reported to aesculap inc., via the annual activl enhanced safety surveillance study (ess) covering a reporting period from 01feb2023 to 31dec2023, that an unknown activ l device was implanted on an unspecified date at the level l4-l5 using spike endplate.According to the complainant there was a supplemental fixation at index level 1.Reportedly the patient's neurological status worsened and there was a disability due to worsening back pain.The adverse event is filed under aic reference (b)(4).Associated medwatch reports: 2916714-2024-00066; 2916714-2024-00065.
|